Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-Blind Randomized Crossover CSII Reservoir In-use Trial of Humalog vs Novorapid in Type 1 Diabetes
2010-018664-16Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Noninferiority of Day 6 Humalog vs Day 6 Novorapid in 7-point daily mean SMBG. Started Jun 2010; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2010-018664-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018664-16.